Innate Immune Effector Recruiting Potential of Hiv-1 Vaccine Induced Antibodies

Grant number: 1036470 | Funding period: 2012 - 2017

Completed

Abstract

A HIV vaccine is urgently needed. A recent human HIV vaccine trial has indicated that Antibody Dependent Cellular Cyotoxicity (ADCC) may be protective. Understanding the role of ADCC HIV-specific antibodies in the context of vaccination has now become one of the most critical questions in HIV vaccine research today. This research aims to comprehensively study ADCC in samples from various HIV Vaccine trials to develop improved vaccine strategies to prevent the devastating consequences of HIV/AIDS.

Related publications (5)

Scholarly works icon

A Functional Role for Antibodies in Tuberculosis

LL Lu, AW Chung, TR Rosebrock, M Ghebremichael, WH Yu, PS Grace, MK Schoen, F Tafesse, C Martin, V Leung, AE Mahan, M Sips, MP Kumar, J Tedesco, H Robinson, E Tkachenko, M Draghi, KJ Freedberg, H Streeck, TJ Suscovich

2016-10-06

While a third of the world carries the burden of tuberculosis, disease control has been hindered by a lack of tools, including a r..

Scholarly works icon

Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees

I Choi, AW Chung, TJ Suscovich, S Rerks-Ngarm, P Pitisuttithum, S Nitayaphan, J Kaewkungwal, RJ O'Connell, D Francis, ML Robb, NL Michael, JH Kim, G Alter, ME Ackerman, C Bailey-Kellogg

2015-04-01

The adaptive immune response to vaccination or infection can lead to the production of specific antibodies to neutralize the patho..

Scholarly works icon

Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines

AW Chung, M Ghebremichael, H Robinson, E Brown, I Choi, S Lane, AS Dugast, MK Schoen, M Rolland, TJ Suscovich, AE Mahan, L Liao, H Streeck, C Andrews, S Rerks-Ngarm, S Nitayaphan, MS De Souza, J Kaewkungwal, P Pitisuttithum, D Francis

2014-03-19

The human phase 2B RV144 ALVAC-HIV vCP1521/AIDSVAX B/E vaccine trial, held in Thailand, resulted in an estimated 31.2% efficacy ag..

Scholarly works icon

Dissecting the antibody constant region protective immune parameters in HIV infection

AW Chung, G Alter

2014-01-01

RV144 vaccine immune-correlates analysis has generated a renewed interest in understanding the potentially protective role of non-..

Scholarly works icon

Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype c vaccine boost in healthy adults

P Hayes, J Gilmour, AV Lieven, D Gill, L Clark, J Kopycinski, H Cheeseman, A Chung, G Alter, L Dally, D Zachariah, A Lombardo, J Ackland, E Sayeed, A Jackson, M Boffito, B Gazzard, PE Fast, JH Cox, D Laufer

2013-03-01

A randomized, double-blind, placebo-controlled phase I trial was conducted in 32 HIV-uninfected healthy volunteers to assess the s..

University of Melbourne Researchers